NasdaqCM - Nasdaq Real Time Price USD

Checkpoint Therapeutics, Inc. (CKPT)

Compare
3.9750
+0.0250
+(0.63%)
As of 2:19:11 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
41
41
103
192
268
Operating Expense
56,215
56,215
52,251
58,525
56,991
Operating Income
-56,174
-56,174
-52,148
-58,333
-56,723
Net Non Operating Interest Income Expense
11
11
84
160
53
Other Income Expense
-77
-77
217
-4,451
--
Pretax Income
-56,240
-56,240
-51,847
-62,624
-56,670
Net Income Common Stockholders
-56,240
-56,240
-51,847
-62,624
-56,670
Diluted NI Available to Com Stockholders
-56,240
-56,240
-51,847
-62,624
-56,670
Basic EPS
-1.83
-1.42
-3.17
-7.09
-7.45
Diluted EPS
-1.83
-1.42
-3.17
-7.09
-7.45
Basic Average Shares
35,028.1220
39,674.4440
18,742.4940
8,835.5210
7,603.1600
Diluted Average Shares
35,028.1220
39,674.4440
18,742.4940
8,835.5210
7,603.1600
Total Operating Income as Reported
-56,174
-56,174
-52,148
-58,333
-56,723
Total Expenses
56,215
56,215
52,251
58,525
56,991
Net Income from Continuing & Discontinued Operation
-56,240
-56,240
-51,847
-62,624
-56,670
Normalized Income
-56,163
-56,163
-52,064
-58,173
-56,670
Interest Income
11
11
84
160
53
Net Interest Income
11
11
84
160
53
EBIT
-56,174
-56,174
-52,148
-58,333
-56,723
EBITDA
-56,174
-56,174
-52,148
-58,333
-56,723
Net Income from Continuing Operation Net Minority Interest
-56,240
-56,240
-51,847
-62,624
-56,670
Total Unusual Items Excluding Goodwill
-77
-77
217
-4,451
--
Total Unusual Items
-77
-77
217
-4,451
--
Normalized EBITDA
-56,097
-56,097
-52,365
-53,882
-56,723
12/31/2021 - 12/19/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

FBIO Fortress Biotech, Inc.
1.4600
+2.08%
 
MBIO Mustang Bio, Inc.
1.3200
+3.90%
 
TGTX TG Therapeutics, Inc.
36.85
+3.72%
 
GLMD Galmed Pharmaceuticals Ltd.
1.4700
+13.08%
 
ABEO Abeona Therapeutics Inc.
4.3400
+0.46%
 
CHRS Coherus BioSciences, Inc.
0.8408
+9.01%
 
MIST Milestone Pharmaceuticals Inc.
0.7145
+9.43%
 
ITRM Iterum Therapeutics plc
1.1400
+2.70%
 
MREO Mereo BioPharma Group plc
1.8750
+6.53%
 
CLRB Cellectar Biosciences, Inc.
0.2475
+2.87%